NAD+ Spray COA: Glow Aminos and Flawless Compounds Share One Ethos Analysis
A reader asked whether Glow Aminos, Flawless Compounds, and Nova Peptides share a NAD+ spray certificate. We re-read the live PDFs: one Ethos sample ID in two brand contexts — not Nova, and not proof of common ownership.
A reader (@JS25181) asked whether a NAD+ spray certificate tied Glow Aminos to Flawless Compounds and Nova Peptides. The left-hand Customer field on that screenshot is Glow Aminos, not Nova. We re-downloaded the live vendor PDFs and compared them field by field.
This is the same class of evidence as the shared-lots article: one laboratory analysis reported in two brand contexts. It is not proof of common ownership, and it is not a finding against Nova Peptides.
Reviewed September 16, 2026 from live vendor-hosted PDFs and both storefront footers. PeptideBenchmark has no affiliate, coupon, sponsorship, or paid-placement relationship with Glow Aminos, Flawless Compounds, or Nova Peptides. Glow Aminos on glowaminos.com is not Glow Peptides. The vendors sell research-use-only products; this is a documentary-evidence review, not human-use guidance or medical advice.
The tweet mixed the left-hand brand
The screenshot’s left certificate is a Glow Aminos print. The printed lot is Gl-010017 (G then lowercase L). That letterform is easy to read as GI-010017; https://glowaminos.com/wp-content/uploads/COA/GI-010017.pdf is not a live file. The live file is GL-010017.pdf.
The right certificate is Flawless Compounds lot FL-010017, still on FL-010017.pdf and on the NAD 1500 mg spray product page.
Both prints carry Ethos sample 26EA0216-021, received 16 Feb 2026, completed 22 Feb 2026, NAD+ 1589.57 mg/bottle versus a 1500 mg / 200-spray label claim. Nova Peptides does not currently host that sample ID.
What we verified from the source documents
| Field | Glow Aminos | Flawless Compounds |
|---|---|---|
| Customer | Glow Aminos | Flawless Compounds |
| EA Sample ID | 26EA0216-021 | 26EA0216-021 |
| Sample name | NAD Liquid Spray | NAD Liquid Spray |
| Batch / lot | Gl-010017 | FL-010017 |
| Received / completed | 02/16/2026 · 02/22/2026 | 02/16/2026 · 02/22/2026 |
| NAD+ result | 1589.57 mg/bottle | 1589.57 mg/bottle |
| Label claim | 1500 mg/bottle (200 sprays) | 1500 mg/bottle (200 sprays) |
| Purity line | Chromatographic purity >98% | Chromatographic purity >98% |
| PDF title | NOV 2026 ETHOS COAS AUTO | NOV 2026 ETHOS COAS AUTO |
| Last modified | 24 Feb 2026 15:36 UTC | 24 Feb 2026 15:37 UTC |
| Source | GL-010017.pdf | FL-010017.pdf |
Nova’s currently published NAD spray PDFs are different analyses, customer Nova Research:
| Field | Nova 1500 mg | Nova 1000 mg |
|---|---|---|
| EA Sample ID | 26EA0618-038 | 26EA0505-049 |
| Sample name | NAD+ 1500MG | NAD+ |
| Batch / lot | NV-S-H9L4 | NV-S-A7K3 |
| Received / completed | 06/18/2026 · 06/21/2026 | 05/05/2026 · 05/11/2026 |
| NAD+ result | 1537.82 mg/bottle | 1026.49 mg/bottle |
| Label claim | 1500 mg/bottle | 1000 mg/bottle |
| PDF title | ETHOS AUTO COAS MAY2026 | ETHOS AUTO COAS MAY2026 |
| Last modified | 31 Aug 2026 | 25 Jun 2026 |
| Source | NAD-1500MG-B1.pdf | NV-S-A7K3 |
The two February files are not byte-identical. The customer name and lot prefix change; the Ethos sample ID, dates, assay, director line (Noel Samsum, 22-Feb-2026), and ISO/IEC 17025:2017 footer do not. Glow’s file last-modified 49 seconds before Flawless’s on 24 Feb 2026.
SHA-256 of the four live files:
- Glow
GL-010017.pdf:dc6b2637a413ed87f430063813897788929f8ed0519b52bf5e238a1feda7aaf2 - Flawless
FL-010017.pdf:8bb1b0fbbb2e0477291fd156a5dff5aca4875e8be4f7af2343d3fc64ddf8859d - Nova 1500 mg:
753ebf2cca937160b64863f60adc103f767c9c301b91b46c23f4d0984e6b0280 - Nova 1000 mg:
52de03deca160b3ae29e90b28edb52adc550f81e8a5c06f4f21e8aafd2a73156
Glow’s catalog still requires a researcher account to browse. Once the filename is known, this PDF downloads without that account.
The rest of that Ethos wave
The NAD pair is not a one-off. The same prefix series runs 010012–010023 (no 010013 on either site). Consecutive Ethos sample IDs 26EA0216-017 through 027. Each Glow PDF matches its Flawless counterpart on sample ID, dates, and assay; each pair differs on customer name and the GL/Gl vs FL lot prefix.
| Lot core | Ethos sample | Assay (both brands) | Glow | Flawless |
|---|---|---|---|---|
| 010012 | 26EA0216-017 | BPC-157 259.16 mcg/capsule vs 250 mcg | capsules · PDF | capsules · PDF |
| 010014 | 26EA0216-018 | Glow blend 2.09 / 0.51 / 0.52 mg/capsule vs 2 / 0.5 / 0.5 mg | Glow blend caps · PDF | Glow caps · PDF |
| 010015 | 26EA0216-019 | Orforglipron 6.22 mg/capsule vs 6 mg | FG-O caps · PDF | FG-O caps · PDF |
| 010016 | 26EA0216-020 | Tesofensine 518.32 mcg/capsule vs 500 mcg | capsules · PDF | capsules · PDF |
| 010017 | 26EA0216-021 | NAD+ 1589.57 mg/bottle vs 1500 mg (200 sprays) | NAD spray · PDF | NAD 1500 mg spray · PDF |
| 010018 | 26EA0216-022 | Semax 52.17 mg/bottle vs 50 mg (200 sprays) | spray · PDF | spray · PDF |
| 010019 | 26EA0216-023 | Selank 40.88 mg/bottle vs 40 mg (200 sprays) | spray · PDF | spray · PDF |
| 010020 | 26EA0216-024 | BPC-157 32.67 mg/bottle vs 30 mg (200 sprays) | spray · PDF | spray · PDF |
| 010021 | 26EA0216-025 | TB-500 32.21 mg/bottle vs 30 mg (200 sprays) | spray · PDF | spray · PDF |
| 010022 | 26EA0216-026 | PT-141 31.94 mg/bottle vs 30 mg (200 sprays) | spray · PDF | spray · PDF |
| 010023 | 26EA0216-027 | BPC-157 / TB-500 32.47 / 32.12 mg/bottle vs 30 / 30 mg (200 sprays) | Wolverine spray · PDF | Wolverine · PDF |
Every file in that table carries the PDF title NOV 2026 ETHOS COAS AUTO. Glow files were last modified 24 Feb 2026 15:36 UTC; Flawless counterparts 15:37 UTC.
Glow’s ILS lots check out under client Glow Aminos on a separate certificate layer. We did not find those same ILS verify addresses reused as Flawless certificates. The identifier that matches here is Ethos’s sample ID on the vendor-hosted PDFs.
How this compares to the chromatogram review
The shared-lots article asserts seven groups only after a human classifies a full-SHA chromatogram. This Ethos wave is the same interpretation — one analysis in two brand contexts — with a stronger lab identifier: Ethos’s own sample ID is identical, not just an embedded image hash.
Lot numbering matches the Northline / Value Research pattern in that article (NLL-7747354 vs VRL-7747354): a shared numeric core with a brand prefix. Here the core is 010017 (Gl- vs FL-).
It is not yet a vendor-profile shared-lot disclosure. That ledger still requires a reviewed chromatogram. Glow Aminos is now a curated vendor; Flawless Compounds is not. Ethos auto-export certificates barely appear in the standing scan (1 Ethos Analytics anomaly vs 1,548 Freedom Diagnostics in the 16 Sep 2026 ledger of 3,177 anomalies). Nova has no reviewed shared-lot chromatogram group in that article.
The storefronts also publish the same New York contact block
The Ethos reprints are not the only overlap a reader can check. On September 16, 2026 both members-only catalogs printed the same footer, with the brand name and support email swapped:
| Field | Glow Aminos | Flawless Compounds |
|---|---|---|
| Street | 1178 Broadway | 1178 Broadway |
| Suite | 3rd Floor, #4433 | 3rd Floor, #4433 |
| City | New York, NY 10001 | New York, NY 10001 |
| Phone | 646-296-6111 | 646-296-6111 |
| [email protected] | [email protected] | |
| Copyright line | © 2025 All Rights Reserved | © 2025 All Rights Reserved |
PeptideBenchmark already maps both storefronts to that Broadway line. It reads as a virtual-office / mailbox address, not a verified manufacturing site. The public landing pages already show those brand-specific emails; the street, suite, and phone appear on the catalog footer once the shop is open.
The two catalogs also look closely related: the same members-only entry, overlapping product names and FG house labels (already noted in the Glow Aminos review), and this near-identical footer layout. That is more sister-storefront / white-label signal. It still does not name an owner, a manufacturer, or which shop supplied the other.
What the evidence does not show
- Who manufactured the liquid.
- Whether Flawless bought from Glow, Glow from Flawless, or both from a third party.
- Shared ownership or management. Matching published contact (same Broadway suite and phone), members-only catalogs, and overlapping house labels are still consistent with a sister storefront, a white-label operator, or a shared virtual office — not a finding of who owns whom.
- That Nova Peptides sold this February 2026 lot. Current Nova NAD spray COAs are 26EA0505-049 (May, 1000 mg,
NV-S-A7K3) and 26EA0618-038 (June, 1500 mg,NV-S-H9L4), customer Nova Research. - Fraud. Contract manufacturing and brand-specific reprints are ordinary. Ethos prints that reports “are prohibited from being reproduced with alterations of any kind.” These look like lab-issued reprints, not a shop editing a PDF.
- The condition of any bottle a reader might later receive.
Any other vendor on this specific COA?
No third brand in PeptideBenchmark’s current COA ledger, Nova’s published NAD PDFs, or the Glow and Flawless certificate PDFs we opened carries sample ID 26EA0216-021. The only two brand contexts on this analysis are Glow Aminos and Flawless Compounds.
Glow Aminos vendor review: Glow Aminos Review. Nova Peptides vendor review: Nova Peptides Review.
Common questions
Does a shared Ethos sample ID mean Glow Aminos and Flawless Compounds are the same company?
No. It shows that one laboratory analysis (Ethos sample 26EA0216-021) was reported in two brand-prefixed certificates. That is consistent with a shared upstream lot or brand-specific reprints of one job. It does not establish common ownership, management, or which storefront supplied the other.
Is the lot GI-010017 or GL-010017?
The live Glow Aminos file is GL-010017.pdf. The printed batch line is Gl-010017 — G then lowercase L — which is easy to misread as GI. The GI-prefixed path 404s. Flawless uses FL-010017 for the same Ethos sample.
Is this the Nova Peptides NAD+ spray COA?
No. Nova's currently published NAD spray PDFs are a 1500 mg bottle (lot NV-S-H9L4, Ethos sample 26EA0618-038, 1537.82 mg/bottle) and a 1000 mg bottle (lot NV-S-A7K3, Ethos sample 26EA0505-049, 1026.49 mg/bottle). Neither carries 26EA0216-021.
Did you only look at the NAD+ spray?
No. After the NAD pair, we downloaded the rest of the February Ethos wave. Eleven Glow GL-0100xx PDFs match eleven Flawless FL-0100xx PDFs on Ethos sample ID, dates, and assay. GL-/FL-010013 is absent on both sites.
Is this fraud?
No. Contract manufacturing and brand-specific laboratory reprints are ordinary. Ethos prints that reports must not be reproduced with alterations; these look like lab-issued brand reprints, not a storefront Photoshopping a PDF. The two NAD files have different SHA-256 hashes because the customer name and lot prefix differ.
Does PeptideBenchmark have an affiliate relationship with these vendors?
No. At the time of this article, PeptideBenchmark had no affiliate, coupon, sponsorship, or paid-placement relationship with Glow Aminos, Flawless Compounds, or Nova Peptides.
Does the shared Broadway address and phone mean Glow Aminos and Flawless Compounds are the same company?
No. Both storefronts currently publish 1178 Broadway, 3rd Floor, #4433, New York, NY 10001 and 646-296-6111, with different brand emails. PeptideBenchmark already maps both to that published line. A shared virtual-office suite and phone is a contact-identity overlap — the same class as overlapping FG labels — not proof of common ownership or management.